Erenumab in Chronic Migraine: An Australian Experience.

CONCLUSION: This is the first report from 3 Australian headache centers about erenumab in the real world. Our analysis has supported erenumab as an effective and well-tolerated migraine preventative therapy for patients with chronic migraine who have failed many preventative therapies. PMID: 32990364 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32990364?dopt=Abstract

Source: Headache - September 28, 2020 Category: Neurology Authors: Cheng S, Jenkins B, Limberg N, Hutton E Tags: Headache Source Type: research

More News: Australia Health | Headache | Migraine | Neurology